Prevent Cancer Foundation leads more than 500 organizations in support of Medicare Multi-Cancer Early Detection Screening Coverage Act in the Senate
F或立即释放
凯拉·梅斯特
703-836-1746
kyra.meister@preventcancer.org
华盛顿特区 - Today, the U.S. Senate introduced bipartisan legislation that recognizes emerging advances in our nation’s fight against cancer by ensuring Medicare can make a coverage decision for new, innovative tests that could detect multiple types of cancer. The Medicare Multi-Cancer Early Detection Screening Coverage Act will allow older Americans with Medicare the possibility of access to multi-cancer early detection (MCED) tests once they are approved by the Food and Drug Administration (FDA) and shown to have clinical benefit. MCED tests, also called liquid biopsies, are blood-based tests, designed to identify the presence of cancer for more than one cancer at a time.
S. 2085 is sponsored by U.S. Sens. Mike Crapo (R-Idaho), Michael Bennet (D-Colo.), Tim Scott (R-S.C.) and Ben Cardin (D-Md.). This legislation modernizes the Medicare program and creates a benefit category for MCED tests, which allows the Centers for Medicare and Medicaid Services (CMS) to initiate an evidenced-based coverage process for multi-cancer tests upon FDA approval.
On March 30, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act was introduced in the U.S. House of Representatives. H.R. 2407 is sponsored by U.S. Reps. Jodey Arrington (R-Texas), Terri Sewell (D-Ala.), Richard Hudson (R-N.C.) and Raul Ruiz (D-Calif.). S. 2085 is the companion bill that brings us one step closer to enabling older Americans with Medicare to access MCED tests. The Prevent Cancer Foundation appreciates the leadership of Sens. Crapo, Bennet, Scott and Cardin on this legislation to ensure that Medicare beneficiaries, and their health care providers, have access to these transformative new early detection tests.
“Without systems driving us forward to ignite change, existing disparities and the number of cancers found in late stages are likely to remain stagnant,” said Jody Hoyos, CEO of the Prevent Cancer Foundation. “We are hopeful that Congress will act swiftly in passing this important legislation.”
Breaking barriers in cancer prevention and early detection is a collective effort, and the Prevent Cancer Foundation is leading the charge. The Foundation is honored to announce that 500+ organizations from every corner of the country have come together to endorse H.R. 2407 and S. 2085. This landmark legislation is a crucial step toward ensuring that older Americans with Medicare have access to these potentially lifesaving tests.
“Science is changing, treatments are improving, but coverage is not keeping up. We need Congress to enable Medicare patients to access the newest lifesaving or life-extending tests and treatments,” said Carole Florman, policy fellow at CancerCare, one of the more than 500 organizations who has signed on to support this legislation.
Read the full letter and view the list of signers. For more information on multi-cancer early detection, visit www.preventcancer.org/early.
###
关于预防癌症基金会®
预防癌症基金会® 是 唯一的美国-基于 非盈利机构 独自 投入的 到 癌症 预防和早期 检测. 通过研究、教育、 外展 和倡导, 我们已经帮助无数人避免癌症诊断或及早发现癌症并得到成功治疗。 我们受到 一个可以预防癌症的世界的愿景， 可检测 并且可击败 对全部.
基金会正努力应对到 2035 年减少 40% 癌症死亡人数的挑战。为了实现这一目标， 我们是 承诺投资 $2000 万美元用于创新技术，以尽早发现癌症并推进 多-癌症筛查，$1000万美元用于扩大癌症筛查和疫苗接种覆盖面 医学上 服务不足的社区，并投入 $10 万美元用于教育公众了解筛查和疫苗接种选择。
如需了解更多信息，请访问 www.preventcancer.org.